Z-1067-2018 Class II Terminated

Recalled by Diagnostica Stago, Inc. — Parsippany, NJ

FDA device recall Z-1067-2018 was initiated by Diagnostica Stago, Inc. on Oct 25, 2017 and is designated Class II. Reason for recall: Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%). The recall status is terminated (terminated May 12, 2020).

Recall details

Product Type
Devices
Report Date
Mar 21, 2018
Initiation Date
Oct 25, 2017
Termination Date
May 12, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Neoplastine¿ Cl Plus ¿ (ref. 00375) Product Usage: Manual or automated determination of the prothrombin time (PT).

Reason for recall

Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).

Distribution pattern

Nationally

Code information

Lot 250080 (Exp: 02-2018) Lot 251762 (Exp: 02-2019) Lot 251940 (Exp: 12-2018)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1067-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1067-2018. Report a data issue: hello@regdatalab.com.